{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ehrlich ascite carcinoma", "benzylidene indanone", "cell cycle", "cytotoxicity", "tubulin polymerization inhibition"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27495835", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "19"}, "DateRevised": {"Year": "2018", "Month": "07", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "08", "Day": "06"}], "ELocationID": ["10.1111/cbdd.12805"], "Language": ["eng"], "Journal": {"ISSN": "1747-0285", "JournalIssue": {"Volume": "88", "Issue": "5", "PubDate": {"Year": "2016", "Month": "Nov"}}, "Title": "Chemical biology & drug design", "ISOAbbreviation": "Chem Biol Drug Des"}, "ArticleTitle": "Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer.", "Pagination": {"StartPage": "625", "EndPage": "634", "MedlinePgn": "625-634"}, "Abstract": {"AbstractText": ["Benzylidene indanones have been designed and synthesized from gallic acid, a plant phenolic acid as possible anticancer agent. The best analogue of the series, that is, 3-(3',4',5'-trimethoxyphenyl)-4,5,6-trimethoxy-2-(4\u02dd-nitrobenzylidene)-indan-1-one (8) exhibited potent cytotoxicity (IC<sub>50</sub> =3-10\u00a0\u03bcm) against several human cancer cell lines through microtubule destabilization (IC<sub>50</sub> =1.54\u00a0\u03bcm) after occupying colchicine-binding site of \u03b2-tubulin. In cell cycle analysis, compound 8 exerted G2/M phase arrest in both MCF-7 and MDA-MB-231 cells and induced apoptosis. It reduced 34.8% solid tumor in in vivo Ehrlich ascite carcinoma in Swiss albino mice at 30\u00a0mg/kg dose. In acute oral toxicity experiment, it was tolerable up to 300\u00a0mg/kg doses in Swiss albino mice. The lead compound 8 needs to be optimized for better activity."], "CopyrightInformation": "\u00a9 2016 John Wiley & Sons A/S."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Singh", "ForeName": "Aastha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Fatima", "ForeName": "Kaneez", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Srivastava", "ForeName": "Ankita", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Khwaja", "ForeName": "Sadiya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, Jammu and Kashmir, India."}], "LastName": "Priya", "ForeName": "Dev", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Singh", "ForeName": "Arjun", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, Jammu and Kashmir, India."}], "LastName": "Mahajan", "ForeName": "Girish", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Alam", "ForeName": "Sarfaraz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity University, Lucknow, Uttar Pradesh, India."}], "LastName": "Saxena", "ForeName": "Ajit K", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, Jammu and Kashmir, India."}], "LastName": "Mondhe", "ForeName": "D M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Chanda", "ForeName": "Debabrata", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India. arvindcimap@rediffmail.com."}], "LastName": "Negi", "ForeName": "Arvind S", "Initials": "AS"}], "PublicationTypeList": ["Editorial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chem Biol Drug Des", "NlmUniqueID": "101262549", "ISSNLinking": "1747-0277"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylidene Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "Indans"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "632XD903SP", "NameOfSubstance": "Gallic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "therapeutic use", "toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Benzylidene Compounds"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Ehrlich Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gallic Acid"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "chemistry", "toxicity"], "DescriptorName": "Indans"}, {"QualifierName": ["drug effects"], "DescriptorName": "M Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Tertiary"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemistry", "therapeutic use", "toxicity"], "DescriptorName": "Tubulin Modulators"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2015", "Month": "11", "Day": "16"}, {"Year": "2016", "Month": "4", "Day": "21"}, {"Year": "2016", "Month": "6", "Day": "2"}, {"Year": "2016", "Month": "8", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "7", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27495835", "10.1111/cbdd.12805"]}}], "PubmedBookArticle": []}